Artas
Founded Year
2002Stage
IPO | IPOTotal Raised
$141.9MDate of IPO
10/12/2017About Artas
Artas is a medical device company, develops and commercializes image-guided robotic systems in the United States and internationally. The company offers ARTAS System, a physician-assisted robotic system that identifies and dissects hair follicular units directly from the scalp and creates recipient implant sites.
Missing: Artas's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Artas's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Artas
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Artas is included in 4 Expert Collections, including Robotics.
Robotics
1,974 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Digital Health
10,338 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Health IT
7,901 items
Artas Patents
Artas has filed 110 patents.
The 3 most popular patent topics include:
- Plastic surgery
- Hair removal
- Human hair
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/28/2017 | 11/29/2022 | Plastic surgery, Cosmetic surgery, Human hair, Transplantation medicine, Implants (medicine) | Grant |
Application Date | 8/28/2017 |
|---|---|
Grant Date | 11/29/2022 |
Title | |
Related Topics | Plastic surgery, Cosmetic surgery, Human hair, Transplantation medicine, Implants (medicine) |
Status | Grant |
Latest Artas News
May 15, 2023
Expected Earnings for Monday Air Industries Group (AIRI) is expected to report for 1Q. Alimera Sciences Inc (ALIM) is expected to report for 1Q. Altus Power Inc (AMPS) is expected to report for 1Q. Aprea Therapeutics Inc (APRE) is expected to report for 1Q. Brainstorm Cell Therapeutics Inc (BCLI) is expected to report $-0.17 for 1Q. Catalent Inc (CTLT) is expected to report $0.19 for 3Q. Catalyst Biosciences Inc (CBIO) is expected to report $-0.07 for 1Q. Centerra Gold is expected to report $-0.02 for 1Q. Clene Inc (CLNN) is expected to report for 1Q. Dorel Industries - B Shares (DII.A.T,DII.B.T,DIIBF) is expected to report for 1Q. Dynacor Group is expected to report for 1Q. Excellon Resources is expected to report for 1Q. Forte Biosciences Inc (FBRX) is expected to report for 1Q. Fulcrum Therapeutics Inc (FULC) is expected to report for 1Q. GT Biopharma Inc (GTBP) is expected to report for 1Q. Galectin Therapeutics (GALT) is expected to report for 1Q. Gatos Silver Inc (GATO) is expected to report for 1Q. Jaguar Mining is expected to report for 1Q. K92 Mining is expected to report for 1Q. Li-Cycle Holdings Corp (LICY) is expected to report for 1Q. Magenta Therapeutics Inc (MGTA) is expected to report $-0.41 for 1Q. McCoy Global is expected to report for 1Q. Minerva Neurosciences Inc (NERV) is expected to report for 1Q. Orbital Infrastructure Group Inc (OIG) is expected to report for 1Q. PDS Biotechnology Corp (PDSB) is expected to report $-0.31 for 1Q. PolarityTE Inc (PTE) is expected to report for 1Q. Premium Brands Holdings (PBH.T,PRBZF) is expected to report for 1Q. SPAR Group Inc (SGRP) is expected to report for 1Q. Stratus Properties (STRS) is expected to report for 1Q. TPG Inc (TPG) is expected to report for 1Q. Terran Orbital Corp (LLAP) is expected to report for 1Q. Tofutti Brands (TOFB) is expected to report for 1Q. Trevena Inc (TRVN) is expected to report for 1Q. Trio-Tech International (TRT) is expected to report for 3Q. VBI Vaccines Inc (VBIV) is expected to report for 1Q. Venus Concept Inc (VERO) is expected to report for 1Q. Vislink Technologies Inc (VISL) is expected to report for 1Q. Workhorse Group Inc (WKHS) is expected to report $-0.18 for 1Q. Zynerba Pharmaceuticals Inc (ZYNE) is expected to report $-0.19 for 1Q. ANALYST RATINGS ACTIONS American States Water Raised to Equal-Weight From Underweight by Wells Fargo Arrowhead Pharmaceuticals Cut to Market Perform From Outperform by SVB Leerink Aveanna Healthcare Cut to Market Perform From Strong Buy by Raymond James Bolt Biotherapeutics Raised to Outperform From Market Perform by SVB Leerink Bright Horizons Family Cut to Neutral From Buy by Citigroup Disney Cut to Peer Perform From Outperform by Wolfe Research Electronic Arts Raised to Buy From Hold by DZ Bank Enovis Raised to Overweight From Equal-Weight by Wells Fargo Estee Lauder Cut to Hold From Buy by Argus Research Fox Corp. Cut to Equal-Weight From Overweight by Wells Fargo Hecla Mining Cut to Hold From Buy by Cantor Fitzgerald Home Point Capital Cut to Neutral From Outperform by Credit Suisse ImmunityBio Cut to Neutral From Overweight by Piper Sandler Mesa Air Group Raised to Market Perform From Underperform by Raymond James Montauk Renewables Raised to Hold From Sell by Tudor Pickering Nauticus Robotics Cut to Neutral From Buy by Chardan Capital ODP Raised to Buy From Hold by CFRA PayPal Holdings Cut to Neutral From Outperform by Exane BNP Paribas SJW Group Cut to Underweight From Equal-Weight by Wells Fargo Spirit Aerosystems Cut to Hold From Strong Buy by CFRA Topgolf Callaway Brands Cut to Hold From Buy by CFRA Twilio Cut to Neutral From Buy by Mizuho This article is a text version of a Wall Street Journal newsletter published earlier today. (END) Dow Jones Newswires
Artas Frequently Asked Questions (FAQ)
When was Artas founded?
Artas was founded in 2002.
Where is Artas's headquarters?
Artas's headquarters is located at 128 Baytech Drive, San Jose.
What is Artas's latest funding round?
Artas's latest funding round is IPO.
How much did Artas raise?
Artas raised a total of $141.9M.
Who are the investors of Artas?
Investors of Artas include InterWest Partners, Alloy Ventures, Sutter Hill Ventures and Clarus.
Who are Artas's competitors?
Competitors of Artas include CMR Surgical, MyoScience, UltraShape, Follica, AesThera and 11 more.
Compare Artas to Competitors
MDSolarSciences develops sun protection, skin care and skin cancer prevention products. The company is committed to providing the safest sunscreens for sensitive skin, rosacea, acne, eczema and psoriasis.
Pacific Shaving Company develops personal care products (for men and women) that are good for the skin, good for the wallet, and good for the earth.
Thermage markets non-invasive skin tightening devices for cosmetic indications. The system heats the deep skin tissues, causing collagen shrinkage, while cooling the skin surface. No incisions are required and side effects associated with lasers are avoided. The technology has multiple potential applications, including treatments for facial skin tightening, acne and acne scarring, stretch marks, breast lifting and fat dissipation. Several types of disposable treatment tips are designed for various applications and anatomic sites. Thermage has secured regulatory clearance for marketing the system.
SpectraGenics is a medical device startup currently in stealth mode. In 2003, this group of esteemed individuals partnered together once again to form SpectraGenics, Inc. They combined their unique talents and assembled an internationally renowned team of experts in the field of aesthetic laser technologies. Soon thereafter, they began developing TRIA. While TRIA continues to roll out in the global marketplace, SpectraGenics continues its development of cutting-edge therapeutic, light-based devices for the global consumer market.
CyDen has developed the SmoothSkin IPL, a device designed to help break the cycle of hair growth.
Applisonix is Applisonix was founded in 2004 with a goal of developing aesthetic solutions that are safe, effective, and suitable for everyone.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.